| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 11/21/2023 | 533.36% | EF Hutton | → $4.5 | Reiterates | Buy → Buy |
| 11/16/2023 | 251.86% | Cantor Fitzgerald | $2.1 → $2.5 | Maintains | Overweight |
| 10/30/2023 | 533.36% | EF Hutton | → $4.5 | Initiates Coverage On | → Buy |
| 08/16/2023 | 181.49% | Cantor Fitzgerald | $3 → $2 | Maintains | Overweight |
| 06/01/2023 | 744.48% | EF Hutton | → $6 | Assumes | → Buy |
| 03/16/2023 | 744.48% | EF Hutton | → $6 | Reiterates | → Buy |
| 02/01/2023 | — | Benchmark | Downgrades | Buy → Hold | |
| 12/19/2022 | 744.48% | EF Hutton | → $6 | Initiates Coverage On | → Buy |
| 08/23/2022 | 603.73% | Maxim Group | $8 → $5 | Maintains | Buy |
| 08/15/2022 | 744.48% | Aegis Capital | $9 → $6 | Maintains | Buy |
| 11/16/2021 | 1166.71% | Aegis Capital | $10 → $9 | Maintains | Buy |
| 03/10/2021 | 1025.97% | Cantor Fitzgerald | → $8 | Initiates Coverage On | → Overweight |
| 01/25/2021 | 1307.46% | Aegis Capital | $8 → $10 | Maintains | Buy |
| 08/19/2020 | 1025.97% | Aegis Capital | $10 → $8 | Maintains | Buy |
| 05/06/2020 | 1307.46% | Aegis Capital | → $10 | Initiates Coverage On | → Buy |
What is the target price for VolitionRX (VNRX)?
The latest price target for VolitionRX (AMEX: VNRX) was reported by EF Hutton on November 21, 2023. The analyst firm set a price target for $4.50 expecting VNRX to rise to within 12 months (a possible 533.36% upside). 8 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for VolitionRX (VNRX)?
The latest analyst rating for VolitionRX (AMEX: VNRX) was provided by EF Hutton, and VolitionRX reiterated their buy rating.
When is the next analyst rating going to be posted or updated for VolitionRX (VNRX)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of VolitionRX, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for VolitionRX was filed on November 21, 2023 so you should expect the next rating to be made available sometime around November 21, 2024.
Is the Analyst Rating VolitionRX (VNRX) correct?
While ratings are subjective and will change, the latest VolitionRX (VNRX) rating was a reiterated with a price target of $0.00 to $4.50. The current price VolitionRX (VNRX) is trading at is $0.71, which is within the analyst's predicted range.